Hirokazu Yagi
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Immunology top 5%
- Cell Biology top 5%
- Epidemiology top 10%
- Co-authors
- Koichi KatoYoshiki YamaguchiYasuo SuzukiSaeko YanakaTadashi SatohShigeru IidaMaho Yagi‐UtsumiTsunehiro Mizushima
- Topics
- Glycosylation and Glycoproteins Research (62 papers)Monoclonal and Polyclonal Antibodies Research (31 papers)Galectins and Cancer Biology (26 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- JapanUnited StatesThailand
In The Last Decade
Hirokazu Yagi
128 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 2.2k
- Radiology, Nuclear Medicine and Imaging 806
- Immunology 711
- Cell Biology 356
- Epidemiology 310
Countries citing papers authored by Hirokazu Yagi
This map shows the geographic impact of Hirokazu Yagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Yagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Yagi more than expected).
Fields of papers citing papers by Hirokazu Yagi
This network shows the impact of papers produced by Hirokazu Yagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Yagi. The network helps show where Hirokazu Yagi may publish in the future.
Co-authorship network of co-authors of Hirokazu Yagi
This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Yagi. A scholar is included among the top collaborators of Hirokazu Yagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Yagi. Hirokazu Yagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 5 | |
| 8 | 7 | |
| 9 | 6 | |
| 10 | 18 | |
| 11 | 16 | |
| 12 | 36 | |
| 13 | 25 | |
| 14 | 39 | |
| 15 | 11 | |
| 16 | 25 | |
| 17 | 51 | |
| 18 | 67 | |
| 19 | 4 | |
| 20 | 74 |
About Hirokazu Yagi
Hirokazu Yagi is a scholar working on Immunology, Cell Biology and Molecular Biology, having authored 133 papers that have together received 2.9k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (62 papers), Monoclonal and Polyclonal Antibodies Research (31 papers) and Galectins and Cancer Biology (26 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (806 citations), Immunology (711 citations) and Molecular Biology (2.2k citations). Hirokazu Yagi has collaborated with scholars based in Japan, United States and Thailand. Frequent co-authors include Koichi Kato, Yoshiki Yamaguchi, Yasuo Suzuki, Saeko Yanaka, Tadashi Satoh, Shigeru Iida, Maho Yagi‐Utsumi, Tsunehiro Mizushima, Robert K. Yu and Takashi Suzuki. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.